Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-25 @ 12:36 PM
NCT ID:
NCT01146795
Group ID:
EG000
Title:
Carboplatin, Paclitaxel, and Bevacizumab
Description:
Three 21 day cycles of carboplatin, paclitaxel, and bevacizumab. After 3 cycles of chemotherapy patients will be considered for surgical cytoreduction. After surgical cytoreduction all patients will receive an additional 6 cycles of chemotherapy (cycles 4-9) regardless of disease status at the time of exploration. Chemotherapy should be re-instituted within 6 weeks of the surgical procedure.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
32
Other Number Affected:
31
Other Number At Risk:
32
Study:
NCT01146795
Results Section:
NCT01146795
Adverse Events Module:
NCT01146795